Detalles de la búsqueda
1.
Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-193672
2.
B.1.1.7 and B.1.351 SARS-CoV-2 variants display enhanced Spike-mediated fusion
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-448011
3.
Syncytia formation by SARS-CoV-2 infected cells
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-202028
4.
The spike-stabilizing D614G mutation interacts with S1/S2 cleavage site mutations to promote the infectious potential of SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-492832
5.
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278699
6.
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20230508
7.
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-475248
8.
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-430472
9.
Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-472630
10.
SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20068858
Resultados
1 -
10
de 10
1
Próxima >
>>